Information technology services

Description

As part of 100 000 Genome Project, Genomics England established a secure Research Environment (RE) to contribute to the realisation of Genomics England’s target benefits which are: — patient benefit, — new scientific insights and discovery, — accelerating the uptake of genomic medicine in the NHS, — stimulating and enhancing UK industry and investment, and — increasing public knowledge and support for genomic medicine. Design, development and operation of the RE are driven by its objective to “provide a secure and collaborative workspace that enables researchers and industry to perform genomic data analysis to accelerate scientific discovery.” A description of the capabilities that are being defined for delivery are provided in a pre-market consultation document within Genomics England e-tendering portal https://genomicsengland.bravosolution.co.uk where you can register interest in the opportunity. As part of 100,000 Genome Project, Genomics England established a secure Research Environment (RE) to contribute to the realisation of Genomics England’s target benefits which are: — patient benefit, — new scientific insights and discovery, — accelerating the uptake of genomic medicine in the NHS, — stimulating and enhancing UK industry and investment, and — increasing public knowledge and support for genomic medicine. Design, development and operation of the RE are driven by its objective to “provide a secure and collaborative workspace that enables researchers and industry to perform genomic data analysis to accelerate scientific discovery.” Below outlines the scope of the RE and the target capabilities that are being delivered as part of a programme of work. A brief description of the capabilities that are to be delivered are provided below. People: — staff appropriately skilled to implement, maintain and support the required data platforms, — recruitment and staff development that maintains the required skills within Genomics England, — organisational structures and resources required to support the effective operation and improvement of the data platforms. Policy and Process: — solutions that drive a standardised approach to data governance, consent practises, data release and other relevant policies and processes, — solutions that enable effective management of data quality, — policies and processes that enable users to work securely, efficiently and effectively in the research environment. Technology: — software and infrastructure that meet functional, security, governance, capacity and performance requirements of the research environment, — technology providing the usability, availability, accessibility, flexibility, interoperability and scalability required by both academic and commercial users. A key component of the RE is a Data and Analytics Platform. The platform will accommodate unstructured, semi-structured and structured data and provide the necessary processing and analytics engines for data transformation and analytics. The scope of this project is to procure, deliver and operationalise a Clinical Data Analytics Platform within the RE. The scope of the Clinical Data Analytics Platform is depicted in the pre-market engagement consultation document. The solution to be delivered will be consistent with overall infrastructure capabilities, conform to corporate security, management and governance policies and deliver the appropriate clinical data and services.